Baxa Corporation’s UK Subsidiary, Baxa Ltd, Announces Direct Sales And Marketing Operations In Austria
September 12, 2006 (PRLEAP.COM) Health News
Ascot, UK – Baxa Ltd announces its move to direct sales and marketing operations in Austria beginning September 1. Baxa products were previously sold through an exclusive distributor, with customer and technical support provided by Baxa Ltd from their European Headquarters in Bracknell, Berkshire. “Having successfully implemented direct operations in France, Belgium and The Netherlands earlier this year, we are looking once again to build on the successes of our Distributor partner and improve both our service and our products through a closer understanding of customer needs,” says Terry Aston, Managing Director, Baxa Ltd.
The move to a direct sales model promotes the company’s strategy of fostering close customer relationships and strengthens Baxa Ltd’s presence in these countries. Baxa currently has direct sales operations in the United Kingdom and Denmark, with area management in Belgium, Germany, Finland, France and the Benelux territories. Baxa also supports distribution partners in 19 other countries in Europe, the Middle East and Africa.
Baxa Ltd provides systems and products that streamline pharmacy operations for oral liquid delivery, sterile IV preparation and mixing multi-source parenteral solutions. The company’s products provide solutions for enhancing patient safety, improving drug preparation procedures and reducing the opportunity for medication errors. The UK operation is a subsidiary of Baxa Corporation, based in Englewood, Colorado.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Key products include Rapid-Fill™ Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and Exacta-Mix™ and MicroMacro™ Multi-Source Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria,Belgium, Denmark, Finland, France, Germany, Luxembourg and The Netherlands; and distribution partners worldwide. Further information is available at http://www.baxa.com
###
Contacts:
Stephanie Scott, Baxa Ltd http://www.baxa.com — Tel +44 (0)1344 890916 – E-mail: s.scott@baxa.co.uk
Maggie Chamberlin Holben, APR Absolutely Public Relations http://www.absolutelypr.com — 303.984.9801 or 303.669.3558 — E-mail: maggie@absolutelypr.com